Air Serbia passenger traffic up 39% y/y in Nov
Kosovo's Ferizai awards Companya Eskavatori road asphalting deal
Moldova's Q3 jobless rate rises to 4.1%
Croatia's industrial PPI down 1.3% y/y in Nov
Slovenia to procure air defence systems from Diehl Defence
Dec 06, 2017 17:24 EEST
SOFIA (Bulgaria), December 6 (SeeNews) – Bulgarian drug maker Sopharma [BUL:3JR] said on Wednesday it has acquired 924,732 of its own shares at an average weighted price of 4.27 levs ($2.6/2.2 euro) apiece as part of its share repurchase programme.
The shares, representing a stake of 0.686% in the company, were bought back in the period December 1 – December 5, Sopharma said in a statement.
On Tuesday, over 6 million Sopharma shares changed hands on the Bulgarian Stock Exchange in a total of 158 transactions at a weighted average price of 4.27 levs apiece ($2.59/2.18 euro), bourse data showed.
Currently, Sopharma holds 6.08 million of its own shares, equal to a 4.51% stake in the company.
Sopharma plans to repurchase 10% of its own shares under the buyback programme approved in June 2010.
(1 euro = 1.95583 levs)
You have run out of free articles this month.
Sign up in for
and get ten (10) free articles per month or sign up for
and get unlimited access.
Browse our free newsletter options